r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with diflunisal in 1 studies
*Diflunisal: A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN. [MeSH]
*Diflunisal: A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN. [MeSH]
| Studies (r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid) | Trials (r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid) | Recent Studies (post-2010) (r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid) | Studies (diflunisal) | Trials (diflunisal) | Recent Studies (post-2010) (diflunisal) |
|---|---|---|---|---|---|
| 17 | 4 | 9 | 605 | 129 | 145 |
| Protein | Taxonomy | r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid (IC50) | diflunisal (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 3.38 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 2.7 | |
| Transthyretin | Homo sapiens (human) | 5.4667 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 0.85 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillmore, JD; Hawkins, PN | 1 |
1 review(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and diflunisal
| Article | Year |
|---|---|
Drug Insight: emerging therapies for amyloidosis.
Topics: Alzheimer Disease; Amyloidosis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carboxylic Acids; Diflunisal; Humans; Immunotherapy; Protein Folding; Pyrrolidines | 2006 |